Monday, February 02, 2026 | 07:23 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

ERIS Lifesciences standalone net profit rises 39.38% in the September 2017 quarter

Capital Market

Sales rise 14.78% to Rs 222.06 crore

Net profit of ERIS Lifesciences rose 39.38% to Rs 92.30 crore in the quarter ended September 2017 as against Rs 66.22 crore during the previous quarter ended September 2016. Sales rose 14.78% to Rs 222.06 crore in the quarter ended September 2017 as against Rs 193.47 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales222.06193.47 15 OPM %42.9737.53 -PBDT102.3379.56 29 PBT97.8374.28 32 NP92.3066.22 39

Powered by Capital Market - Live News

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 20 2017 | 5:35 PM IST

Explore News